Reaction Details Report a problem with these data
Target
Beta-lactamase
Ligand
BDBM361210
Substrate
n/a
IC50
0.098±n/a nM
Citation
 Bennett, F; Jiang, J; Pasternak, A; Dong, S; Gu, X; Scott, JD; Tang, H; Zhao, Z; Huang, Y; Yang, D; Young, K; Xiao, L; Zhang, Z; Fu, J Metallo-beta-lactamase inhibitors US Patent  US10544130 Publication Date 1/28/2020 
Target
Name:
Beta-lactamase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29508.45
Organism:
n/a
Description:
Q2QC95
Residue:
266
Sequence:
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
 
Inhibitor
Name:
BDBM361210
Synonyms:
(R)-4-(2-aminobenzo[d]thiazol-4-yl)-N1-((3-aminopyrrolidin-3-yl)methyl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide | US10221163, Example 367 | US10544130, Example 367
Type:
Small organic molecule
Emp. Form.:
C19H22N10O4S3
Mol. Mass.:
550.638
SMILES:
Nc1nc2c(cccc2s1)-c1ccc(c(c1-c1nn[nH]n1)S(N)(=O)=O)S(=O)(=O)NC[C@@]1(N)CCNC1 |r|
Structure:
Search PDB for entries with ligand similarity: